Serum levels of dehydroepiandrosterone sulfate (DHEAS) in ocular toxoplasmosis

Alejandra De-la-Torre, Angela Cristina Ríos-Cadavid, Carlos Mario Cardozo-García, Leonardo Padilla, Jorge Enrique Gómez-Marín

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


There are no previous study about ocular toxoplasmosis and serum levels of dehydroepiandrosterone sulphated hormone (DHEAS). We use the chemoluminiscence automatized Immulite assay to determine the levels of DHEAS. Four groups were studied: (1) Individuals with chronic asymptomatic infection with a positive test for IgG anti-Toxoplasma and without ocular lesions (n = 16); (2) Chronic asymptomatic patients with retinal scars of retinochoroiditis by Toxoplasma (n = 19); (3) Acute symptomatic patients with active retinochoroiditis by Toxoplasma (n = 26); (4) Individuals with negative assays for IgG anti-Toxoplasma (n = 21). Comparison of DHEAS levels between groups were adjusted by age and sex and non-parametric Kruskall Wallis statistical tests were applied. No significant differences in serum levels of DHEAS were found between groups when age and sex were controlled. DHEAS levels were not significantly different in active ocular toxoplasmosis related to non active or non infected persons. © 2011.
Translated title of the contribution Niveles séricos de sulfato de dehidroepiandrosterona (DHEAS) en la toxoplasmosis ocular
Original languageEnglish (US)
Pages (from-to)65-68
Number of pages4
JournalJournal of Microbiology, Immunology and Infection
StatePublished - Feb 1 2012
Externally publishedYes


Dive into the research topics of 'Serum levels of dehydroepiandrosterone sulfate (DHEAS) in ocular toxoplasmosis'. Together they form a unique fingerprint.

Cite this